Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 251 (RNA5SP251) is a pseudogene—an inactive, non-functional fragment or copy—derived from the 5S ribosomal RNA gene family[2][5]. While canonical 5S ribosomal RNA (5S rRNA) is an essential structural RNA component of the large ribosomal subunit, the pseudogene version lacks the ability to encode a functional RNA product and is generally considered non-functional. It has no known biological activity, ligand, or role as a drug target. Pseudogenes like RNA5SP251 are abundant in the genome and may participate in evolutionary or regulatory processes, but specific functional or pathological relevance for RNA5SP251 has not been documented. Some studies have shown that expression levels of certain pseudogenes, in aggregate, can serve as markers in cancer, but no such evidence is available for this particular pseudogene[4].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 251 (RNA5SP251).